BSEJYOTI RESINS & ADHESIVES LTD.· Chemicals & PetrochemicalsHighNeutral
Announced Tue, 11 Aug, 2026 · 12:56 IST

Q1 FY27 results: Revenue up 17%, but PAT falls 32% on higher costs

Ebitda Margin CompressionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-6.5%Reaction day
₹889.50
prior close
₹890.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-6.3% vs market
Specialty Chemicals peers, median of 97sector+0.0%-6.5% vs sector

On the reaction day the stock moved 6.3 pts less than Nifty Microcap 250 and 6.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-6.2
10m
-4.8
15m
-4.7
30m
-4.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-6.5-0.2-6.3+0.0-6.5
Next day
-5.6+0.2-5.8+0.0-5.6
2d
-2.5+0.4-2.9+0.2-2.7
3d
-2.2+0.4-2.6+0.7-2.9
4d
—+0.6—+0.2—
5d
—+0.9—-0.1—
1w
—+0.9—+0.1—
15d
—+0.9—+0.6—
1m
—+2.3—+0.4—
2m
—-1.1—-1.5—
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 97Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jyoti Resins Q1 FY27 revenue from operations rose 16.8% to Rs 8,771 lakhs from Rs 7,510 lakhs YoY. However, total expenses surged 37.6% to Rs 7,556 lakhs, dragging net profit down 32.4% to Rs 1,175 lakhs from Rs 1,738 lakhs. PBT margin compressed sharply to 17.6% from 30.9%. Cost of materials consumed jumped from Rs 2,375 to Rs 5,221 lakhs. EPS fell to Rs 10 from Rs 14. Statutory auditors issued a clean limited review report.

Likely market impact

Higher raw material costs hurt profitability despite revenue growth. Sharp margin compression is a key concern; watch for cost normalization.